Determination of nonalcoholic fatty liver disease in patients with pre-impaired glucose tolerance

Valdez Valerie Ann U; Mercado-Asis Leilani B; Lopez Amy A; Mendoza Erick S; Barredo Katherine Jane G; Sollano José D; Milo Abigail M; Milo Mario T.
Philippine Journal of Internal Medicine ; : 1-6, 2017.
Artículo en Inglés | WPRIM | ID: wpr-633444

Documentos relacionados

  1. Determination of nonalcoholic fatty liver disease in patients with pre-impaired glucose tolerance
  2. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.
  3. Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.
  4. Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease.
  5. A high-fat diet supplemented with medium-chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice.
  6. High-fat diet-induced nonalcoholic steatohepatitis is accelerated by low carnitine and impaired glucose tolerance in novel murine models.
  7. INFLUENCE OF COMPLEX TREATMENT ON BIOCHEMICAL BLOOD PARAMETERS OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND CONCOMITANT PRE-DIABETES.
  8. Trajectories of glycaemic traits exhibit sex-specific associations with hepatic iron and fat content: Results from the KORA-MRI study.